NanoString raises $15.3 million in E round

Diagnostics company NanoString Technologies Inc. (Seattle, Wash.) raised $15.3 million in a series E round. New investors Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment participated. All of NanoString's existing investors also participated, including Clarus Ventures; Draper Fish Jurvetson; OVP Venture Partners; GE healthymagination Fund; Biomed Ventures; and Henri Termeer, the former chairman, president and CEO of Genzyme Corp., which Sanofi (Euronext:SAN; NYSE:SNY) acquired. ...